Literature DB >> 28839638

Improving outpatient services: the Southampton IBD virtual clinic.

Jo Hunter1, Andrew Claridge1, Shirley James1, David Chan1, Bernard Stacey1, Mike Stroud1, Praful Patel1, David Fine1, J R Fraser Cummings1.   

Abstract

The follow-up of inflammatory bowel disease (IBD) patients is challenging due to the relapsing remitting nature of the diseases, the wide spectrum of severity and complexity as well as the need for monitoring of long-term complications and drug treatments. Conventional outpatient follow-up lacks flexibility for patients and there are competing pressures for clinic time. Alternative follow-up pathways include telephone clinics, self-management programmes or discharging patients. The IBD virtual clinic (VC) is a further option. Patients with an established diagnosis for >2 years, who have been stable for >1 year, do not have primary sclerosing cholangitis and who give their consent, are entered into the VC system. Two months before their annual follow-up is due patients are sent blood test forms and a simple questionnaire with an information sheet. If they meet any of the criteria on the questionnaire, they are asked to contact the IBD specialist nursing team to discuss their situation. The blood test results and the patient's database entry are reviewed to ensure that they are not due surveillance investigations. The patients and their GPs then receive a letter informing them of their management plan. We currently follow-up 20% of the Southampton IBD cohort using the VC. The VC system is an innovative, efficient and patient-responsive method for following up mild to moderate IBD. It is well liked by patients but is dependent on a well-maintained database with good integration of IT systems and requires both clerical and IBD nurse specialist support.

Entities:  

Year:  2012        PMID: 28839638      PMCID: PMC5517268          DOI: 10.1136/flgastro-2012-100123

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  9 in total

1.  Non-attendance at clinic: cycles of audit of a consultant based gastroenterology outpatient department.

Authors:  M C Bateson
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

Review 2.  Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).

Authors:  Stuart R Cairns; John H Scholefield; Robert J Steele; Malcolm G Dunlop; Huw J W Thomas; Gareth D Evans; Jayne A Eaden; Matthew D Rutter; Wendy P Atkin; Brian P Saunders; Anneke Lucassen; Paul Jenkins; Peter D Fairclough; Christopher R J Woodhouse
Journal:  Gut       Date:  2010-05       Impact factor: 23.059

3.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.

Authors:  A Dignass; G Van Assche; J O Lindsay; M Lémann; J Söderholm; J F Colombel; S Danese; A D'Hoore; M Gassull; F Gomollón; D W Hommes; P Michetti; C O'Morain; T Oresland; A Windsor; E F Stange; S P L Travis
Journal:  J Crohns Colitis       Date:  2010-01-15       Impact factor: 9.071

Review 4.  Medical management of Crohn's disease.

Authors:  J R Fraser Cummings; Satish Keshav; Simon P L Travis
Journal:  BMJ       Date:  2008-05-10

5.  Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1999--2000.

Authors:  Catharine W Burt; Susan M Schappert
Journal:  Vital Health Stat 13       Date:  2004-09

6.  Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.

Authors:  Michael D Kappelman; Sheryl L Rifas-Shiman; Carol Q Porter; Daniel A Ollendorf; Robert S Sandler; Joseph A Galanko; Jonathan A Finkelstein
Journal:  Gastroenterology       Date:  2008-09-17       Impact factor: 22.682

7.  Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study.

Authors:  A Bassi; S Dodd; P Williamson; K Bodger
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 8.  Guidelines for the management of inflammatory bowel disease in adults.

Authors:  Craig Mowat; Andrew Cole; Al Windsor; Tariq Ahmad; Ian Arnott; Richard Driscoll; Sally Mitton; Tim Orchard; Matt Rutter; Lisa Younge; Charlie Lees; Gwo-Tzer Ho; Jack Satsangi; Stuart Bloom
Journal:  Gut       Date:  2011-05       Impact factor: 23.059

9.  Reasons for and consequences of missed appointments in general practice in the UK: questionnaire survey and prospective review of medical records.

Authors:  Richard D Neal; Mahvash Hussain-Gambles; Victoria L Allgar; Debbie A Lawlor; Owen Dempsey
Journal:  BMC Fam Pract       Date:  2005-11-07       Impact factor: 2.497

  9 in total
  5 in total

1.  The impact of an inflammatory bowel disease nurse-led biologics service.

Authors:  Nicola S Taylor; Marion Bettey; Julia Wright; Caron Underhill; Sarah Kerr; Kim Perry; Jr Fraser Cummings
Journal:  Frontline Gastroenterol       Date:  2016-07-07

2.  Insight from patients and healthcare professionals on the implementation of virtual clinics in patients with inflammatory bowel disease.

Authors:  Aditi Kumar; Mohammed Nabil Quraishi; Shanika de Silva; Nigel John Trudgill; Helen Steed; Matthew James Brookes; Rachel Cooney
Journal:  Frontline Gastroenterol       Date:  2021-02-25

3.  Stratification of inflammatory bowel disease outpatients by disease activity and risk of complications to guide out-of-hospital monitoring: a patient-centred quality improvement project.

Authors:  Rishi K Fofaria; Susan Barber; Yewande Adeleke; Tom Woodcock; Nikolaos Kamperidis; Alaa Mohamed; Ravi Misra; Ajit Shah; Susan Bailey-Fee; Howard Bluston; Denise Robinson; Tracey Tyrrell; Naila Arebi
Journal:  BMJ Open Qual       Date:  2019-08-01

4.  Delivering outpatient virtual clinics during the COVID-19 pandemic: early evaluation of clinicians' experiences.

Authors:  Venessa Vas; Shirley North; Tiago Rua; Daniella Chilton; Michaela Cashman; Bharti Malhotra; Toby Garrood
Journal:  BMJ Open Qual       Date:  2022-01

5.  Using telemedicine and wearable technology to establish a virtual clinic for people with Parkinson's disease.

Authors:  Lauren Evans; Biju Mohamed; Edward Christopher Thomas
Journal:  BMJ Open Qual       Date:  2020-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.